HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer.

AuthorsM J Harding, B M Cantwell, R A Milstead, A L Harris, S B Kaye
JournalBritish journal of cancer (Br J Cancer) Vol. 57 Issue 6 Pg. 628-9 (Jun 1988) ISSN: 0007-0920 [Print] England
PMID3408648 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Quinazolines
  • CB 3717
  • Folic Acid
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Colonic Neoplasms (drug therapy)
  • Drug Evaluation
  • Female
  • Folic Acid (adverse effects, analogs & derivatives, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Quinazolines (adverse effects, therapeutic use)
  • Rectal Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: